RESUMEN
Testis-specific transcript 10 (Tex10) is a critical factor for pluripotent stem cell maintenance and preimplantation development. Here, we dissect its late developmental roles in primordial germ cell (PGC) specification and spermatogenesis using cellular and animal models. We discover that Tex10 binds the Wnt negative regulator genes, marked by H3K4me3, at the PGC-like cell (PGCLC) stage in restraining Wnt signaling. Depletion and overexpression of Tex10 hyperactivate and attenuate the Wnt signaling, resulting in compromised and enhanced PGCLC specification efficiency, respectively. Using the Tex10 conditional knockout mouse models combined with single-cell RNA sequencing, we further uncover critical roles of Tex10 in spermatogenesis with Tex10 loss causing reduced sperm number and motility associated with compromised round spermatid formation. Notably, defective spermatogenesis in Tex10 knockout mice correlates with aberrant Wnt signaling upregulation. Therefore, our study establishes Tex10 as a previously unappreciated player in PGC specification and male germline development by fine-tuning Wnt signaling.
RESUMEN
Motor impairment after stroke is generally caused by damage to the neural networks that control movement. Corticomuscular coherence (CMC) is a valid method to analyze the functional connectivity of the corticospinal pathway between the cerebral cortex and muscles. However, current studies on CMC in stroke patients only focused on the upper limbs. The functional connectivity between the brain and lower limbs in stroke patients has not been well studied. Therefore, twelve stroke patients and fifteen healthy controls were recruited and their electroencephalogram (EEG) and electromyogram (EMG) of Tibialis Anterior (TA), Lateral Gastrocnemius (LG) and Medial Gastrocnemius (MG) during unilateral static ankle dorsiflexion were recorded. We found the mean beta and gamma CMC values of Cz electrode of stroke patients were significantly lower than those of healthy controls (p < 0.05). The brain topography showed significant coherence in the center of the cerebral cortex in healthy controls, while there was no significant coherence in stroke patients. For clinical assessment, there was a significant positive correlation between CMC and lower limb Fugl-Meyer Assessment (FMA) for Cz-TA in beta band (r = 0.6296, p = 0.0282), Cz-LG in beta band (r = 0.6816, p = 0.0147), and Cz-MG in gamma band (r = 0.6194, p = 0.0317). A multiple linear regression model was established between CMC and lower limb FMA ( R2 = 0.6600 , p = 0.0280). Therefore, CMC between the cerebral cortex and lower limb muscles may be used as a new rehabilitation assessment biomarker in stroke.
Asunto(s)
Tobillo , Accidente Cerebrovascular , Humanos , Tobillo/fisiología , Músculo Esquelético/fisiología , Electromiografía/métodos , ElectroencefalografíaRESUMEN
Background: Cancer stem cells (CSCs) are highly tumorigenic, chemotherapy-resistant, tumor growth-sustaining, and are implicated in tumor recurrence. Previous studies have shown that lysine-specific histone demethylase 1A (KDM1A) is highly expressed in several human malignancies and CSCs. However, the role of KDM1A in CSCs and the therapeutic potential of KDM1A inhibitors for the treatment of the advanced thyroid cancer are poorly understood. Methods: Firstly, KDM1A was identified as an important epigenetic modifier that maintained the stemness of thyroid cancer through a mini histone methylation modifier screen and confirmed in thyroid cancer tissues and cell lines. RNA sequence was performed to discover the downstream genes of KDM1A. The underlying mechanisms were further investigated by ChIP, IP and dual luciferase reporter assays, gain and loss of function assays. Results: Here we report that KDM1A regulates the stemness of thyroid cancer and promotes thyroid cancer progression via the Wnt/ß-catenin pathway. Mechanistically, KDM1A down-regulates two antagonists of the canonical Wnt pathway, APC2 and DKK1, by demethylating H3K4me1/2 of the APC2 promoter region and the nonhistone substrate HIF-1α, resulting in the inhibition of APC2 transcription and the activation of the HIF-1α/microRNA-146a/DKK1 axis. Importantly, we also demonstrate that GSK-LSD1, a highly selective inhibitor of KDM1A, significantly inhibits thyroid cancer progression and enhances the sensitivity of thyroid cancer to chemotherapy. Conclusions: KDM1A plays an important role in thyroid cancer progression and maintains stemness, our study provides a new strategy for the therapy of advanced thyroid cancer.
Asunto(s)
Neoplasias de la Tiroides , Vía de Señalización Wnt , Línea Celular Tumoral , Regulación Neoplásica de la Expresión Génica , Histona Demetilasas/metabolismo , Humanos , Recurrencia Local de Neoplasia/genética , Células Madre Neoplásicas/metabolismo , Neoplasias de la Tiroides/metabolismo , Vía de Señalización Wnt/genética , beta Catenina/genética , beta Catenina/metabolismoRESUMEN
Electroencephalogram (EEG) is a basic physiological signal of human body, which can effectively record the nervous system activities of the brain and contains rich information. The synchronization of EEG signals is not only the key to the exchange of information between different brain regions, but also reflects the neural activity of the brain, which in turn can infer people's cognitive activities. Therefore, studying the phase synchronization of EEG signals after stroke is of great significance for understanding the communication and neuroplasticity of neurons after brain injury. In this paper, the changes of EEG phase synchronization in bilateral, cyclical ankle movements alternately after stroke were studied by Hilbert transform. Ten stroke patients and six healthy adults participated in the test. The results showed that the inter-hemisphere phase synchronization index (inter-PSI) and the global PSI of patients were significantly lower than that of the healthy subjects during the task. The PSI between Cz and the affected sensory cortex associated with lower limb movements was also significantly lower than that in the control group. There was a significant negative correlation between National Institutes of Health Stroke Scale (NIHSS) and cortical synchronization. The above results indicated that PSI under ankle alternating movements may be used as a new biomarker to evaluate the recovery of patients' brain neurons.
Asunto(s)
Tobillo , Accidente Cerebrovascular , Adulto , Encéfalo , Sincronización Cortical , Electroencefalografía , Humanos , Estados UnidosRESUMEN
Papillary thyroid carcinoma (PTC) is one of the most common kinds of endocrine-related cancer and has a heterogeneous prognosis. Metabolic reprogramming is one of the hallmarks of cancers. Aberrant glucose metabolism is associated with malignant biological behavior. However, the functions and mechanisms of glucose metabolism genes in PTC are not fully understood. Thus, data from The Cancer Genome Atlas database were analyzed, and lactate dehydrogenase A (LDHA) was determined to be a potential novel diagnostic and therapeutic target for PTCs. The research objective was to investigate the expression of LDHA in PTCs and to explore the main functions and relative mechanisms of LDHA in PTCs. Higher expression levels of LDHA were found in PTC tissues than in normal thyroid tissues at both the mRNA and protein levels. Higher expression levels of LDHA were correlated with aggressive clinicopathological features and poor prognosis. Moreover, we found that LDHA not only promoted PTC migration and invasion but also enhanced tumor growth both in vitro and in vivo. In addition, we revealed that the metabolic products of LDHA catalyzed induced the epithelial-mesenchymal transition process by increasing the relative gene H3K27 acetylation. Moreover, LDHA knockdown activated the AMPK pathway and induced protective autophagy. An autophagy inhibitor significantly enhanced the antitumor effect of FX11. These results suggested that LDHA enhanced the cell metastasis and proliferation of PTCs and may therefore become a potential therapeutic target for PTCs.
Asunto(s)
Autofagia/efectos de los fármacos , Movimiento Celular/efectos de los fármacos , Lactato Deshidrogenasa 5/farmacología , Metástasis de la Neoplasia/tratamiento farmacológico , Cáncer Papilar Tiroideo/genética , Carcinogénesis/efectos de los fármacos , Carcinogénesis/genética , Movimiento Celular/genética , Proliferación Celular/efectos de los fármacos , Transformación Celular Neoplásica/efectos de los fármacos , Transformación Celular Neoplásica/genética , Transición Epitelial-Mesenquimal/genética , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Regulación Neoplásica de la Expresión Génica/genética , Humanos , Lactato Deshidrogenasa 5/metabolismo , Cáncer Papilar Tiroideo/tratamiento farmacológico , Neoplasias de la Tiroides/tratamiento farmacológico , Neoplasias de la Tiroides/metabolismoRESUMEN
Error-related potentials (ErrPs) can reflect the brain's response to errors. Recently, it has been used in the studies on neural mechanisms of human cognition, such as error detection and conflict monitoring. Moreover, ErrPs have provided technical support for the development of brain-computer interface (BCI). However, the different effects of visual stimulation modes (dynamic or static) on ErrPs have not been revealed. This may seriously affect the recognition accuracy of the ErrPs in practical applications. Therefore, the aim of this study was to investigate how people respond to different types of visual stimulations. Nineteen participants were recruited in the ErrPs-based tasks with two visual stimulation modes (dynamic and static). The ErrPs were analyzed and the feature values (N1, P2, P3, N6 and P8, named by the occurrence time) were statistically compared. The results showed that the difference between correctness and error was reflected in P3, N6, P8 in dynamic stimulation; and N1, P3, N6 and P8 in static stimulation. In the event-related potential based on error, the differences between dynamic and static tasks were reflected in N1 and P2. In conclusion, this study found that the features with later occurrence were significantly affected by correctness and error in both cases, while the error-related change in N1 only existed under the static stimulation. We also found that the recognition of stimulation modes came earlier within about 300 ms after the start of visual stimulation.
Asunto(s)
Interfaces Cerebro-Computador , Electroencefalografía , Encéfalo , Potenciales Evocados , Humanos , Estimulación LuminosaRESUMEN
Error-related potentials (ErrPs) have provided technical support for the brain-computer interface. However, different visual stimulations may affect the ErrPs, and furthermore, affect the error recognition based on ErrPs. Therefore, the study aimed to investigate how people respond to different visual stimulations (static and dynamic) and find the best time window for different stimulation. Nineteen participants were recruited in the ErrPs-based tasks with static and dynamic visual stimulations. Five ErrPs were statistically compared, and the classification accuracies were obtained through linear discriminant analysis (LDA) with nine different time windows. The results showed that the P3, N6, and P8 with correctness were significantly different from those with error in both stimulations, while N1 only existed in static. The differences between dynamic and static errors existed in N1 and P2. The highest accuracy was obtained in the time window related to N1, P3, N6, and P8 for the static condition, and in the time window related to P3, N6, and P8 for the dynamic. In conclusion, the early components of ErrPs may be affected by stimulation modes, and the late components are more sensitive to errors. The error recognition with static stimulation requires information from the entire epoch, while the late windows should be focused more within the dynamic case.
Asunto(s)
Interfaces Cerebro-Computador , Encéfalo/fisiología , Electroencefalografía , Estimulación Luminosa , HumanosRESUMEN
There is no effective treatment for patients with poorly differentiated papillary thyroid cancer or anaplastic thyroid cancer (ATC). Anlotinib, a multi-kinase inhibitor, has already shown antitumor effects in various types of carcinoma in a phase I clinical trial. In this study, we aimed to better understand the effect and efficacy of anlotinib against thyroid carcinoma cells in vitro and in vivo. We found that anlotinib inhibits the cell viability of papillary thyroid cancer and ATC cell lines, likely due to abnormal spindle assembly, G2/M arrest, and activation of TP53 upon anlotinib treatment. Moreover, anlotinib suppresses the migration of thyroid cancer cells in vitro and the growth of xenograft thyroid tumors in mice. Our data demonstrate that anlotinib has significant anticancer activity in thyroid cancer, and potentially offers an effective therapeutic strategy for patients of advanced thyroid cancer type.
Asunto(s)
Antineoplásicos/uso terapéutico , Indoles/uso terapéutico , Inhibidores de Proteínas Quinasas/uso terapéutico , Quinolinas/uso terapéutico , Cáncer Papilar Tiroideo/tratamiento farmacológico , Carcinoma Anaplásico de Tiroides/tratamiento farmacológico , Neoplasias de la Tiroides/tratamiento farmacológico , Animales , Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Humanos , Indoles/farmacología , Masculino , Ratones Endogámicos BALB C , Ratones Desnudos , Inhibidores de Proteínas Quinasas/farmacología , Quinolinas/farmacología , Cáncer Papilar Tiroideo/metabolismo , Cáncer Papilar Tiroideo/patología , Carcinoma Anaplásico de Tiroides/metabolismo , Carcinoma Anaplásico de Tiroides/patología , Neoplasias de la Tiroides/metabolismo , Neoplasias de la Tiroides/patología , Proteína p53 Supresora de Tumor/metabolismoRESUMEN
Ten-eleven translocation (TET) proteins play key roles in the regulation of DNA-methylation status by oxidizing 5-methylcytosine (5mC) to generate 5-hydroxymethylcytosine (5hmC), which can both serve as a stable epigenetic mark and participate in active demethylation. Unlike the other members of the TET family, TET2 does not contain a DNA-binding domain, and it remains unclear how it is recruited to chromatin. Here we show that TET2 is recruited by the RNA-binding protein Paraspeckle component 1 (PSPC1) through transcriptionally active loci, including endogenous retroviruses (ERVs) whose long terminal repeats (LTRs) have been co-opted by mammalian genomes as stage- and tissue-specific transcriptional regulatory modules. We found that PSPC1 and TET2 contribute to ERVL and ERVL-associated gene regulation by both transcriptional repression via histone deacetylases and post-transcriptional destabilization of RNAs through 5hmC modification. Our findings provide evidence for a functional role of transcriptionally active ERVs as specific docking sites for RNA epigenetic modulation and gene regulation.
Asunto(s)
Cromatina/metabolismo , Proteínas de Unión al ADN/metabolismo , Retrovirus Endógenos/fisiología , Proteínas Nucleares/metabolismo , Células Madre Pluripotentes/metabolismo , Proteínas Proto-Oncogénicas/metabolismo , Proteínas de Unión al ARN/metabolismo , ARN/fisiología , Animales , Células Cultivadas , Cromatina/genética , Metilación de ADN , Dioxigenasas , Epigénesis Genética/fisiología , Femenino , Células HEK293 , Humanos , Masculino , Ratones , Unión ProteicaRESUMEN
The Hippo pathway modulates the transcriptional activity of Yap to regulate the differentiation of the inner cell mass (ICM) and the trophectoderm (TE) in blastocysts. Yet how Hippo signaling is differentially regulated in ICM and TE cells is poorly understood. Through an inhibitor/activator screen, we have identified Rho as a negative regulator of Hippo in TE cells, and PKA as a positive regulator of Hippo in ICM cells. We further elucidated a novel mechanism by which Rho suppresses Hippo, distinct from the prevailing view that Rho inhibits Hippo signaling through modulating cytoskeleton remodeling and/or cell polarity. Active Rho prevents the phosphorylation of Amot Ser176, thus stabilizing the interaction between Amot and F-actin, and restricting the binding between Amot and Nf2. Moreover, Rho attenuates the interaction between Amot and Nf2 by binding to the coiled-coil domain of Amot. By blocking the association of Nf2 and Amot, Rho suppresses Hippo in TE cells.
Asunto(s)
Blastocisto/citología , Blastocisto/metabolismo , Péptidos y Proteínas de Señalización Intercelular/metabolismo , Proteínas de Microfilamentos/metabolismo , Neurofibromina 2/metabolismo , Transducción de Señal , Proteínas de Unión al GTP rho/metabolismo , Actinas/metabolismo , Angiomotinas , Animales , Línea Celular , Membrana Celular/metabolismo , Polaridad Celular , Proteínas Quinasas Dependientes de AMP Cíclico/metabolismo , Citoesqueleto/metabolismo , Ectodermo/citología , Ectodermo/metabolismo , Femenino , Péptidos y Proteínas de Señalización Intercelular/química , Ratones Endogámicos ICR , Proteínas de Microfilamentos/química , Modelos Biológicos , Fosforilación , Unión Proteica , Dominios Proteicos , Quinasas Asociadas a rho/metabolismoRESUMEN
Phosphorylation of Ezrin T567 plays an important role in eight-cell embryo compaction. Yet, it is not clear how Ezrin phosphorylation is regulated during embryo compaction. Here, we demonstrated that inhibition of Mek/Erk or protein kinase C (PKC) signaling reduced the phosphorylation level of Ezrin T567 in eight-cell compacted embryos. Interestingly, the Rho GTPase inhibitor C3-transferase caused basolateral enrichment of atypical PKC (aPKC), as well as basolateral shift of phosphorylated Ezrin, suggesting aPKC may be a key regulator of Ezrin phosphorylation. Moreover, inhibition of PKC, but not Mek/Erk or Rho GTPases, affected the maintenance of Ezrin phosphorylation in compacted embryos. We further identified that aPKC is indeed required for Ezrin phosphorylation in eight-cell embryos. Taken together, Rho GTPases facilitate the apical distribution of aPKC and Ezrin. Subsequently, aPKC and Mek/Erk work together to promote Ezrin phosphorylation at the apical region, which in turn mediates the apical enrichment of filamentous actin, stabilizing the polarized apical region and allowing embryo compaction. Our data also suggested that aPKC might be the Ezrin kinase during eight-cell embryo compaction.